Oct 6, 2005 (CIDRAP News) – Recent US government contracts to test two experimental anthrax drugs could lead to the purchase of up to 100,000 doses of each.Cangene, based in Winnipeg, Man., has received a contract from the Office of Public Health Emergency Preparedness in the Department of Health and Human Services (HHS) to supply its anthrax immune globulin (AIG) for preliminary efficacy testing, according to a company news release. The company describes AIG as a hyperimmune product for treating or preventing inhalational anthrax, caused by Bacillus anthracis.HHS has the next year to decide whether to purchase from 10,000 to 100,000 doses of AIG over three years. If that happens, Cangene must seek Food and Drug Administration approval of the product.HHS has awarded a similar contract to Human Genome Sciences Inc. (HGS) of Rockville, Md. In the first phase of the contract, worth $1.8 million, the company will sell the government 10 grams of ABthrax, a human monoclonal antibody for treating anthrax, the company announced on Oct 3. The government then will have the option to buy up to 100,000 doses of the product within a year.B anthracis is considered a category A bioweapon. Four years ago this month, soon after the Sep 11 attacks, anthrax spores sent through the US mail caused a series of anthrax cases that eventually totaled 22 (11 cutaneous and 11 inhalational). Five patients with inhalational anthrax died. The case has never been solved.See also: CIDRAP anthrax overviewhttp://www.cidrap.umn.edu/cidrap/content/bt/anthrax/biofacts/index.html
Odion Ighalo’s Deadline Day move to Manchester United is proof the club can no longer attract the world’s best strikers, according to Eidur Gudjohnsen.Advertisement Read Also: Man United Move: It is now Eagles need Ighalo, Rohr“They needed somebody in. I think he was not their number one and I would be surprised if he was their number two or three as well.“He is getting an opportunity and he will definitely get minutes and we will see if he can do it.”Hasselbaink also says United’s struggles in the transfer market are even harder to understand after they sold Romelu Lukaku last summer and loaned Alexis Sanchez both to Inter Milan.He added: “They knew that they needed a new striker for a long time. I don’t know how much money that they have but it is Manchester United.FacebookTwitterWhatsAppEmail分享 Former Watford striker Ighalo eventually emerged as United’s answer on loan until the end of the season, having earlier been unsuccessful in signing Erling Braut Haaland, who opted for Borusssia Dortmund, and Bournemouth’s Joshua King.Former Chelsea forward Gudjohnsen told the Transfer Talk podcast United were always going to struggle to recruit a top calibre striker during the January window.Asked how far back United have fallen, Gudjohnsen said: “It comes back to the time of the season of this [Ighalo] transfer as well. I don’t think any of the best strikers are available.” Loading… He added: “I don’t think any of the best strikers are eager to join United anymore.”Jimmy Floyd Hasselbaink says Ighalo, who has played in China since January 2017, is unlikely to have even been a third choice target for United.“He must be the luckiest man! Going to China, being away from Europe nobody seeing him for two and a half years since he was at Watford and then getting a loan move at United,” he said.“Wow. That doesn’t happen!“It says how far behind United are from Liverpool, Manchester City and even Chelsea. They have got a big job ahead. A largely uneventful January transfer window ended with United in a frantic last-gasp search for a striker to bolster their attacking options in the absence of injured England international Marcus Rashford.